APO Research
Talk to an analyst

APO RESEARCH · REPORT

IL-23p19 Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global IL-23p19 Inhibitors Industry Growth and Trends Forecast to 2032

26 December 202592 pages

Choose your research edition.

Industry ResearchIL-23p19 Inhibitors Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal IL-23p19 Inhibitors Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal IL-23p19 Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IL-23p19 Inhibitors Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal IL-23p19 Inhibitors Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global IL-23p19 Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for IL-23p19 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for IL-23p19 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IL-23p19 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of IL-23p19 Inhibitors include Innovent Biologics (Suzhou) Co. Ltd., Johnson & Johnson, Merck Sharp & Dohme Corp., Eli Lilly and AbbVie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global IL-23p19 Inhibitors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The IL-23p19 Inhibitors market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global IL-23p19 Inhibitors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to IL-23p19 Inhibitors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global IL-23p19 Inhibitors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

IL-23p19 Inhibitors Market by Company

Innovent Biologics (Suzhou) Co. Ltd.

Johnson & Johnson

Merck Sharp & Dohme Corp.

Eli Lilly

AbbVie

IL-23p19 Inhibitors Segment by Type

100mg/mL

75mg/mL

IL-23p19 Inhibitors Segment by Application

Hospital

Clinic

Others

IL-23p19 Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IL-23p19 Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IL-23p19 Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IL-23p19 Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of IL-23p19 Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of IL-23p19 Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100mg/mL Table 2. Major Company of 75mg/mL Table 3. Global IL-23p19 Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units) Table 5. Global IL-23p19 Inhibitors Sales Market Share in Volume by Type (2021-2026) Table 6. Global IL-23p19 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 7. Global IL-23p19 Inhibitors Sales Market Share in Value by Type (2021-2026) Table 8. Global IL-23p19 Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 9. Global IL-23p19 Inhibitors Sales by Type (2027-2032) & (K Units) Table 10. Global IL-23p19 Inhibitors Sales Market Share in Volume by Type (2027-2032) Table 11. Global IL-23p19 Inhibitors Sales by Type (2027-2032) & (US$ Million) Table 12. Global IL-23p19 Inhibitors Sales Market Share in Value by Type (2027-2032) Table 13. Global IL-23p19 Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 14. North America IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units) Table 15. North America IL-23p19 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 16. Europe IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units) Table 17. Europe IL-23p19 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific IL-23p19 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units) Table 21. Latin America IL-23p19 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa IL-23p19 Inhibitors Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa IL-23p19 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 24. IL-23p19 Inhibitors Industry Trends Table 25. IL-23p19 Inhibitors Industry Drivers Table 26. IL-23p19 Inhibitors Industry Opportunities and Challenges Table 27. IL-23p19 Inhibitors Industry Restraints Table 28. Global IL-23p19 Inhibitors Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global IL-23p19 Inhibitors Revenue Market Share by Company (2021-2026) Table 30. Global IL-23p19 Inhibitors Sales by Company (2021-2026) & (K Units) Table 31. Global IL-23p19 Inhibitors Sales Share by Company (2021-2026) Table 32. Global IL-23p19 Inhibitors Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global IL-23p19 Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global IL-23p19 Inhibitors Major Company Production Sites and Headquarters Table 35. Global IL-23p19 Inhibitors Company, Product Type & Application Table 36. Global IL-23p19 Inhibitors Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global IL-23p19 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global IL-23p19 Inhibitors Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global IL-23p19 Inhibitors Sales by Region (2021-2026) & (K Units) Table 41. Global IL-23p19 Inhibitors Sales Market Share in Volume by Region (2021-2026) Table 42. Global IL-23p19 Inhibitors Sales by Region (2021-2026) & (US$ Million) Table 43. Global IL-23p19 Inhibitors Sales Market Share in Value by Region (2021-2026) Table 44. Global IL-23p19 Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global IL-23p19 Inhibitors Sales by Region (2027-2032) & (K Units) Table 46. Global IL-23p19 Inhibitors Sales Market Share in Volume by Region (2027-2032) Table 47. Global IL-23p19 Inhibitors Sales by Region (2027-2032) & (US$ Million) Table 48. Global IL-23p19 Inhibitors Sales Market Share in Value by Region (2027-2032) Table 49. Global IL-23p19 Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global IL-23p19 Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global IL-23p19 Inhibitors Sales by Application (2021-2026) & (K Units) Table 52. Global IL-23p19 Inhibitors Sales Market Share in Volume by Application (2021-2026) Table 53. Global IL-23p19 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 54. Global IL-23p19 Inhibitors Sales Market Share in Value by Application (2021-2026) Table 55. Global IL-23p19 Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 56. Global IL-23p19 Inhibitors Sales by Application (2027-2032) & (K Units) Table 57. Global IL-23p19 Inhibitors Sales Market Share in Volume by Application (2027-2032) Table 58. Global IL-23p19 Inhibitors Sales by Application (2027-2032) & (US$ Million) Table 59. Global IL-23p19 Inhibitors Sales Market Share in Value by Application (2027-2032) Table 60. Global IL-23p19 Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 61. North America IL-23p19 Inhibitors Sales by Application (2021-2026) & (K Units) Table 62. North America IL-23p19 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 63. Europe IL-23p19 Inhibitors Sales by Application (2021-2026) & (K Units) Table 64. Europe IL-23p19 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific IL-23p19 Inhibitors Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific IL-23p19 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America IL-23p19 Inhibitors Sales by Application (2021-2026) & (K Units) Table 68. Latin America IL-23p19 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa IL-23p19 Inhibitors Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa IL-23p19 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 71. Innovent Biologics (Suzhou) Co. Ltd. Company Information Table 72. Innovent Biologics (Suzhou) Co. Ltd. Business Overview Table 73. Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Product Portfolio Table 75. Innovent Biologics (Suzhou) Co. Ltd. Recent Development Table 76. Johnson & Johnson Company Information Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson IL-23p19 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Johnson & Johnson IL-23p19 Inhibitors Product Portfolio Table 80. Johnson & Johnson Recent Development Table 81. Merck Sharp & Dohme Corp. Company Information Table 82. Merck Sharp & Dohme Corp. Business Overview Table 83. Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Product Portfolio Table 85. Merck Sharp & Dohme Corp. Recent Development Table 86. Eli Lilly Company Information Table 87. Eli Lilly Business Overview Table 88. Eli Lilly IL-23p19 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Eli Lilly IL-23p19 Inhibitors Product Portfolio Table 90. Eli Lilly Recent Development Table 91. AbbVie Company Information Table 92. AbbVie Business Overview Table 93. AbbVie IL-23p19 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. AbbVie IL-23p19 Inhibitors Product Portfolio Table 95. AbbVie Recent Development Table 96. North America IL-23p19 Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. North America IL-23p19 Inhibitors Sales by Country (2021-2026) & (K Units) Table 98. North America IL-23p19 Inhibitors Sales Market Share by Country (2021-2026) Table 99. North America IL-23p19 Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 100. North America IL-23p19 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 101. North America IL-23p19 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America IL-23p19 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 103. North America IL-23p19 Inhibitors Market Share by Country (2021-2026) Table 104. North America IL-23p19 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America IL-23p19 Inhibitors Market Share Forecast by Country (2027-2032) Table 106. Europe IL-23p19 Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Europe IL-23p19 Inhibitors Sales by Country (2021-2026) & (K Units) Table 108. Europe IL-23p19 Inhibitors Sales Market Share by Country (2021-2026) Table 109. Europe IL-23p19 Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 110. Europe IL-23p19 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 111. Europe IL-23p19 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe IL-23p19 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe IL-23p19 Inhibitors Market Share by Country (2021-2026) Table 114. Europe IL-23p19 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe IL-23p19 Inhibitors Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific IL-23p19 Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific IL-23p19 Inhibitors Sales by Country (2021-2026) & (K Units) Table 118. Asia-Pacific IL-23p19 Inhibitors Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific IL-23p19 Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 120. Asia-Pacific IL-23p19 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific IL-23p19 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific IL-23p19 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific IL-23p19 Inhibitors Market Share by Country (2021-2026) Table 124. Asia-Pacific IL-23p19 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific IL-23p19 Inhibitors Market Share Forecast by Country (2027-2032) Table 126. Latin America IL-23p19 Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Latin America IL-23p19 Inhibitors Sales by Country (2021-2026) & (K Units) Table 128. Latin America IL-23p19 Inhibitors Sales Market Share by Country (2021-2026) Table 129. Latin America IL-23p19 Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 130. Latin America IL-23p19 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America IL-23p19 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America IL-23p19 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America IL-23p19 Inhibitors Market Share by Country (2021-2026) Table 134. Latin America IL-23p19 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America IL-23p19 Inhibitors Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa IL-23p19 Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa IL-23p19 Inhibitors Sales by Country (2021-2026) & (K Units) Table 138. Middle East and Africa IL-23p19 Inhibitors Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa IL-23p19 Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 140. Middle East and Africa IL-23p19 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa IL-23p19 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa IL-23p19 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa IL-23p19 Inhibitors Market Share by Country (2021-2026) Table 144. Middle East and Africa IL-23p19 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa IL-23p19 Inhibitors Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. IL-23p19 Inhibitors Distributors List Table 149. IL-23p19 Inhibitors Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. IL-23p19 Inhibitors Image Figure 2. Global IL-23p19 Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IL-23p19 Inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global IL-23p19 Inhibitors Sales (2021-2032) & (K Units) Figure 5. 100mg/mL Image Figure 6. Global 100mg/mL Sales YoY Growth (2021-2032) & (K Units) Figure 7. 75mg/mL Image Figure 8. Global 75mg/mL Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global IL-23p19 Inhibitors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global IL-23p19 Inhibitors Market Share by Type 2025 VS 2032 Figure 11. North America IL-23p19 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 12. North America IL-23p19 Inhibitors Sales Market Share in Value by Type in 2025 Figure 13. Europe IL-23p19 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 14. Europe IL-23p19 Inhibitors Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific IL-23p19 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific IL-23p19 Inhibitors Sales Market Share in Value by Type in 2025 Figure 17. Latin America IL-23p19 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 18. Latin America IL-23p19 Inhibitors Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa IL-23p19 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa IL-23p19 Inhibitors Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 IL-23p19 Inhibitors Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global IL-23p19 Inhibitors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global IL-23p19 Inhibitors Market Share by Application 2025 VS 2032 Figure 31. North America IL-23p19 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 32. North America IL-23p19 Inhibitors Sales Market Share in Value by Application in 2025 Figure 33. Europe IL-23p19 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 34. Europe IL-23p19 Inhibitors Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific IL-23p19 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific IL-23p19 Inhibitors Sales Market Share in Value by Application in 2025 Figure 37. Latin America IL-23p19 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 38. Latin America IL-23p19 Inhibitors Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa IL-23p19 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa IL-23p19 Inhibitors Sales Market Share in Value by Application in 2025 Figure 41. North America IL-23p19 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America IL-23p19 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America IL-23p19 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America IL-23p19 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe IL-23p19 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe IL-23p19 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe IL-23p19 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe IL-23p19 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific IL-23p19 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific IL-23p19 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific IL-23p19 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific IL-23p19 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America IL-23p19 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America IL-23p19 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America IL-23p19 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America IL-23p19 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa IL-23p19 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa IL-23p19 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa IL-23p19 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa IL-23p19 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. IL-23p19 Inhibitors Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. IL-23p19 Inhibitors Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg/mL
  • 75mg/mL
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Innovent Biologics (Suzhou) Co. Ltd.
  • Johnson & Johnson
  • Merck Sharp & Dohme Corp.
  • Eli Lilly
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global IL-23p19 Inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global IL-23p19 Inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.3 IL-23p19 Inhibitors Market by Type
  6. 1.3.1 100mg/mL
  7. 1.3.2 75mg/mL
  8. 1.4 Global IL-23p19 Inhibitors Market Size by Type
  9. 1.4.1 Global IL-23p19 Inhibitors Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global IL-23p19 Inhibitors Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global IL-23p19 Inhibitors Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America IL-23p19 Inhibitors Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe IL-23p19 Inhibitors Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific IL-23p19 Inhibitors Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America IL-23p19 Inhibitors Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa IL-23p19 Inhibitors Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 IL-23p19 Inhibitors Industry Trends
  2. 2.2 IL-23p19 Inhibitors Industry Drivers
  3. 2.3 IL-23p19 Inhibitors Industry Opportunities and Challenges
  4. 2.4 IL-23p19 Inhibitors Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by IL-23p19 Inhibitors Revenue (2021-2026)
  2. 3.2 Global Top Players by IL-23p19 Inhibitors Sales (2021-2026)
  3. 3.3 Global Top Players by IL-23p19 Inhibitors Price (2021-2026)
  4. 3.4 Global IL-23p19 Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global IL-23p19 Inhibitors Major Company Production Sites & Headquarters
  6. 3.6 Global IL-23p19 Inhibitors Company, Product Type & Application
  7. 3.7 Global IL-23p19 Inhibitors Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global IL-23p19 Inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 IL-23p19 Inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 IL-23p19 Inhibitors Tier 1, Tier 2, and Tier 3
4 IL-23p19 Inhibitors Regional Status and Outlook
  1. 4.1 Global IL-23p19 Inhibitors Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global IL-23p19 Inhibitors Historic Market Size by Region
  3. 4.2.1 Global IL-23p19 Inhibitors Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global IL-23p19 Inhibitors Sales in Value by Region (2021-2026)
  5. 4.2.3 Global IL-23p19 Inhibitors Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global IL-23p19 Inhibitors Forecasted Market Size by Region
  7. 4.3.1 Global IL-23p19 Inhibitors Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global IL-23p19 Inhibitors Sales in Value by Region (2027-2032)
  9. 4.3.3 Global IL-23p19 Inhibitors Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 IL-23p19 Inhibitors by Application
  1. 5.1 IL-23p19 Inhibitors Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global IL-23p19 Inhibitors Market Size by Application
  6. 5.2.1 Global IL-23p19 Inhibitors Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global IL-23p19 Inhibitors Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global IL-23p19 Inhibitors Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America IL-23p19 Inhibitors Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe IL-23p19 Inhibitors Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific IL-23p19 Inhibitors Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America IL-23p19 Inhibitors Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa IL-23p19 Inhibitors Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Innovent Biologics (Suzhou) Co. Ltd.
  2. 6.1.1 Innovent Biologics (Suzhou) Co. Ltd. Company Information
  3. 6.1.2 Innovent Biologics (Suzhou) Co. Ltd. Business Overview
  4. 6.1.3 Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Innovent Biologics (Suzhou) Co. Ltd. IL-23p19 Inhibitors Product Portfolio
  6. 6.1.5 Innovent Biologics (Suzhou) Co. Ltd. Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson IL-23p19 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson IL-23p19 Inhibitors Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Merck Sharp & Dohme Corp.
  14. 6.3.1 Merck Sharp & Dohme Corp. Company Information
  15. 6.3.2 Merck Sharp & Dohme Corp. Business Overview
  16. 6.3.3 Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Sharp & Dohme Corp. IL-23p19 Inhibitors Product Portfolio
  18. 6.3.5 Merck Sharp & Dohme Corp. Recent Developments
  19. 6.4 Eli Lilly
  20. 6.4.1 Eli Lilly Company Information
  21. 6.4.2 Eli Lilly Business Overview
  22. 6.4.3 Eli Lilly IL-23p19 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Eli Lilly IL-23p19 Inhibitors Product Portfolio
  24. 6.4.5 Eli Lilly Recent Developments
  25. 6.5 AbbVie
  26. 6.5.1 AbbVie Company Information
  27. 6.5.2 AbbVie Business Overview
  28. 6.5.3 AbbVie IL-23p19 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AbbVie IL-23p19 Inhibitors Product Portfolio
  30. 6.5.5 AbbVie Recent Developments
7 North America by Country
  1. 7.1 North America IL-23p19 Inhibitors Sales by Country
  2. 7.1.1 North America IL-23p19 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America IL-23p19 Inhibitors Sales by Country (2021-2026)
  4. 7.1.3 North America IL-23p19 Inhibitors Sales Forecast by Country (2027-2032)
  5. 7.2 North America IL-23p19 Inhibitors Market Size by Country
  6. 7.2.1 North America IL-23p19 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America IL-23p19 Inhibitors Market Size by Country (2021-2026)
  8. 7.2.3 North America IL-23p19 Inhibitors Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe IL-23p19 Inhibitors Sales by Country
  2. 8.1.1 Europe IL-23p19 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe IL-23p19 Inhibitors Sales by Country (2021-2026)
  4. 8.1.3 Europe IL-23p19 Inhibitors Sales Forecast by Country (2027-2032)
  5. 8.2 Europe IL-23p19 Inhibitors Market Size by Country
  6. 8.2.1 Europe IL-23p19 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe IL-23p19 Inhibitors Market Size by Country (2021-2026)
  8. 8.2.3 Europe IL-23p19 Inhibitors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific IL-23p19 Inhibitors Sales by Country
  2. 9.1.1 Asia-Pacific IL-23p19 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific IL-23p19 Inhibitors Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific IL-23p19 Inhibitors Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific IL-23p19 Inhibitors Market Size by Country
  6. 9.2.1 Asia-Pacific IL-23p19 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific IL-23p19 Inhibitors Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific IL-23p19 Inhibitors Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America IL-23p19 Inhibitors Sales by Country
  2. 10.1.1 South America IL-23p19 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America IL-23p19 Inhibitors Sales by Country (2021-2026)
  4. 10.1.3 South America IL-23p19 Inhibitors Sales Forecast by Country (2027-2032)
  5. 10.2 South America IL-23p19 Inhibitors Market Size by Country
  6. 10.2.1 South America IL-23p19 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America IL-23p19 Inhibitors Market Size by Country (2021-2026)
  8. 10.2.3 South America IL-23p19 Inhibitors Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa IL-23p19 Inhibitors Sales by Country
  2. 11.1.1 Middle East and Africa IL-23p19 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa IL-23p19 Inhibitors Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa IL-23p19 Inhibitors Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa IL-23p19 Inhibitors Market Size by Country
  6. 11.2.1 Middle East and Africa IL-23p19 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa IL-23p19 Inhibitors Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa IL-23p19 Inhibitors Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 IL-23p19 Inhibitors Value Chain Analysis
  2. 12.1.1 IL-23p19 Inhibitors Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 IL-23p19 Inhibitors Production Mode & Process
  7. 12.2 IL-23p19 Inhibitors Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 IL-23p19 Inhibitors Distributors
  10. 12.2.3 IL-23p19 Inhibitors Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst